Evangelos Triantafyllou

2.6k total citations · 1 hit paper
41 papers, 1.2k citations indexed

About

Evangelos Triantafyllou is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Evangelos Triantafyllou has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 18 papers in Immunology and 15 papers in Hepatology. Recurrent topics in Evangelos Triantafyllou's work include Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (15 papers) and Immune Cell Function and Interaction (6 papers). Evangelos Triantafyllou is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (15 papers) and Immune Cell Function and Interaction (6 papers). Evangelos Triantafyllou collaborates with scholars based in United Kingdom, Greece and United States. Evangelos Triantafyllou's co-authors include Charalambos G. Antoniades, Lucia Possamai, Mark McPhail, Julia Wendon, Kevin Woollard, Christine Bernsmeier, Arjuna Singanayagam, Vishal Patel, William Bernal and Mark Thursz and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Evangelos Triantafyllou

36 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial

2015 421 citations Fin Stolze Larsen, Christine Bernsmeier et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evangelos Triantafyllou United Kingdom	14	739	595	345	274	271	41	1.2k
Christoph Jochum Germany	23	725 1.0×	827 1.4×	168 0.5×	174 0.6×	412 1.5×	68	1.5k
Manuel Mendizábal Argentina	17	502 0.7×	610 1.0×	156 0.5×	77 0.3×	245 0.9×	65	1.1k
Nobuaki Nakayama Japan	18	925 1.3×	775 1.3×	300 0.9×	58 0.2×	256 0.9×	72	1.2k
Ziv Ben‐Ari Israel	27	1.2k 1.6×	1.1k 1.8×	111 0.3×	139 0.5×	455 1.7×	91	2.0k
Gerald Denk Germany	23	615 0.8×	647 1.1×	190 0.6×	78 0.3×	504 1.9×	63	1.5k
Satoshi Mochida Japan	16	586 0.8×	432 0.7×	185 0.5×	45 0.2×	297 1.1×	39	880
Hubert Louis Belgium	18	355 0.5×	404 0.7×	95 0.3×	216 0.8×	761 2.8×	34	1.5k
Francesco Azzaroli Italy	24	708 1.0×	724 1.2×	126 0.4×	162 0.6×	638 2.4×	77	1.7k
Martin F. Sprinzl Germany	25	801 1.1×	817 1.4×	46 0.1×	300 1.1×	210 0.8×	69	1.6k
Paul Manka Germany	19	621 0.8×	695 1.2×	132 0.4×	29 0.1×	186 0.7×	59	1.1k

Countries citing papers authored by Evangelos Triantafyllou

Since Specialization

Citations

This map shows the geographic impact of Evangelos Triantafyllou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Triantafyllou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Triantafyllou more than expected).

Fields of papers citing papers by Evangelos Triantafyllou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Triantafyllou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Triantafyllou. The network helps show where Evangelos Triantafyllou may publish in the future.

Co-authorship network of co-authors of Evangelos Triantafyllou

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Triantafyllou. A scholar is included among the top collaborators of Evangelos Triantafyllou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Triantafyllou. Evangelos Triantafyllou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arsenopoulos, Konstantinos V., et al.. (2025). Hematological Parameters of Clinically Healthy Indigenous Greek Goats (Capra prisca) and Their Associations with Parasitological Findings, Age and Reproductive Stage. Agriculture. 15(13). 1445–1445.

Liu, Tong, Gang Wu, Cathrin Gudd, et al.. (2024). Cis-interaction between CD52 and T cell receptor complex interferes with CD4+ T cell activation in acute decompensation of cirrhosis. EBioMedicine. 108. 105336–105336.

Gudd, Cathrin, Stephen R. Atkinson, Samra Turajlic, et al.. (2024). Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis. Journal for ImmunoTherapy of Cancer. 12(4). e008078–e008078. 3 indexed citations

Triantafyllou, Evangelos, Cathrin Gudd, & Lucia Possamai. (2024). Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management. Nature Reviews Gastroenterology & Hepatology. 22(2). 112–126. 8 indexed citations

Pallis, Dimitrios, et al.. (2024). Patella Fracture After Total Knee Arthroplasty: A Review. Cureus. 16(1). e53281–e53281.

Cavazza, Anna, Evangelos Triantafyllou, Salma Mujib, et al.. (2024). Macrophage activation markers are associated with infection and mortality in patients with acute liver failure. Liver International. 44(8). 1900–1911. 3 indexed citations

Artru, Florent, et al.. (2023). Potential therapies for acute‐on‐chronic liver failure. Liver International. 45(3). e15545–e15545. 10 indexed citations

Gudd, Cathrin, et al.. (2023). Immune Checkpoint Inhibitor-Induced Liver Injury. Seminars in Liver Disease. 43(4). 402–417. 5 indexed citations

Delo, Joseph, Daniel Forton, Evangelos Triantafyllou, & Arjuna Singanayagam. (2023). Peritoneal Immunity in Liver Disease. SHILAP Revista de lepidopterología. 3(2). 240–257.

10.

Gudd, Cathrin, Lewis Au, Evangelos Triantafyllou, et al.. (2021). Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis. Journal of Hepatology. 75(1). 177–189. 43 indexed citations

11.

Papadakis, Stamatios A, et al.. (2021). Peroneus brevis tendon injuries: Report of two cases and review of literature. Trauma Case Reports. 35. 100524–100524. 2 indexed citations

12.

Triantafyllou, Evangelos, Cathrin Gudd, Francesca M. Trovato, et al.. (2020). PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury. Journal of Clinical Investigation. 131(4). 80 indexed citations

13.

Pop, Oltin T., Evangelos Triantafyllou, Arjuna Singanayagam, et al.. (2019). Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis. Life Science Alliance. 3(1). e201900465–e201900465. 30 indexed citations

14.

Lebossé, Fanny, Cathrin Gudd, Arjuna Singanayagam, et al.. (2019). CD8+ T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction. EBioMedicine. 49. 258–268. 69 indexed citations

15.

Singanayagam, Arjuna, Rooshi Nathwani, Evangelos Triantafyllou, et al.. (2018). PTH-106 Plasma S100A8/A9: a novel mechanistic biomarker in innate immune activation in acute-on-chronic liver failure. A131.2–A132. 1 indexed citations

16.

Khamri, Wafa, R.D. Abeles, Tie Zheng Hou, et al.. (2017). Increased Expression of Cytotoxic T-Lymphocyte−Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure. Gastroenterology. 153(1). 263–276.e8. 37 indexed citations

17.

Bernsmeier, Christine, Evangelos Triantafyllou, Fanny Lebossé, et al.. (2017). CD14 ⁺ CD15 ⁻ HLA-DR ⁻ myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. Gut. 67(6). 1155–1167. 100 indexed citations

18.

McPhail, Mark, Evangelos Triantafyllou, Debbie L. Shawcross, et al.. (2013). Increased apoptotic activity is associated with hospital mortality and disruption in lipid homeostasis in acute-on-chronic liver failure.. Hepatology. 58. 1 indexed citations

19.

Triantafyllou, Evangelos, R.D. Abeles, Alberto Quaglia, et al.. (2013). 1013 CD163 IS A MECHANISTIC BIOMARKER IN ACUTE LIVER FAILURE REFLECTING A MACROPHAGE ACTIVATION LIKE SYNDROME. Journal of Hepatology. 58. S417–S417. 2 indexed citations

20.

Spyridonidis, Alexandros, Maria Liga, Evangelos Triantafyllou, et al.. (2010). Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia. Bone Marrow Transplantation. 46(10). 1363–1368. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact